PRKN and Parkinson disease: Dawson et al.37 proposed that a ‘true' parkin substrate should accumulate in both AR-JP and sporadic PD as well as in animal models of parkin inactivation such as PaKO mice and the MPTP toxin model.37 Our previous19, 23 and present work appears to fulfill these requirements37 for RTP801.